Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer, on October 31, 2023. The filing serves to disclose updates to the Company's Bylaws adopted during the Shareholders' General Meeting held on June 27, 2023.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a corporate governance disclosure and does not contain financial performance data.
Material Changes
The material change disclosed is the restatement of the Company's Bylaws to incorporate updates approved by shareholders on June 27, 2023. No financial or operational changes are reported in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, or discussion of contingencies. The document is limited to the submission of the updated Bylaws as Exhibit 99.1.
Key Facts for Investors
- The Company updated its Bylaws effective June 27, 2023.
- The updated Bylaws are filed as Exhibit 99.1 to this report.
- This filing is incorporated by reference into the Company's registration statements on Form F-3 and Form S-8.
- No financial results or operational metrics are included in this specific filing.